Nifty
Sensex
:
:
24211.00
77616.40
4.10 (0.02%)
47.01 (0.06%)

Pharmaceuticals & Drugs - Domestic

Rating :
67/99

BSE: 500488 | NSE: ABBOTINDIA

27395.00
13-Jul-2026
  • Open
  • High
  • Low
  • Previous Close
  •  27490
  •  27530
  •  27170
  •  27165.00
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  10100
  •  276360020
  •  35310
  •  25150

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 58,189.73
  • 37.49
  • 10
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 55,934.78
  • 2.40%
  • 12.19

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 74.99%
  • 0.71%
  • 13.38%
  • FII
  • DII
  • Others
  • 0.27%
  • 8.72%
  • 1.93%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 9.38
  • 8.26
  • 6.21

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 16.62
  • 12.99
  • 7.02

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 18.68
  • 15.41
  • 14.21

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 48.49
  • 48.40
  • 47.11

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 14.92
  • 15.20
  • 15.34

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 31.11
  • 32.37
  • 31.59

Earnings Forecasts:

(Updated: 11-07-2026)
Description
2026
2027
2028
2029
Adj EPS
52
-19
10.42
738.88
P/E Ratio
526.83
-1441.84
2629.08
37.08
Revenue
31.68
28.56
25.74
6953.54
EBITDA
7521.41
8187.53
9001.63
1895.4
Net Income
2098.39
2326.13
2561.27
1570.1
ROA
1725.65
1914.28
2123.7
24.14
P/B Ratio
-11.50
-10.19
-10.77
12.72
ROE
10.58
9.18
7.96
34.99
FCFF
34.28
34.28
34.32
1283.31
FCFF Yield
1766.16
1740.09
1750.05
2.44
Net Debt
3.36
3.31
3.33
-1758.55
BVPS
-2383
-2688.85
-2543.1
2154.36

Quarterly Results

Standalone Figures in Rs. Crores /

Consolidated
Description
Mar 26
Mar 25
Var%
Dec 25
Dec 24
Var%
Sep 25
Sep 24
Var%
Jun 25
Jun 24
Var%
Net Sales
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
Expenses
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
EBITDA
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
EBIDTM
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
Other Income
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
Interest
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
Depreciation
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
PBT
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
Tax
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
PAT
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
PATM
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
EPS
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0

Annual Results

Standalone Figures in Rs. Crores /

Consolidated
Description
TTM
Nov 01
Net Sales
-
356.31
Net Sales Growth
-
 
Cost Of Goods Sold
-
182.40
Gross Profit
-
173.91
GP Margin
-
48.81%
Total Expenditure
-
305.87
Power & Fuel Cost
-
2.92
% Of Sales
-
0.82%
Employee Cost
-
21.63
% Of Sales
-
6.07%
Manufacturing Exp.
-
16.42
% Of Sales
-
4.61%
General & Admin Exp.
-
9.79
% Of Sales
-
2.75%
Selling & Distn. Exp.
-
63.11
% Of Sales
-
17.71%
Miscellaneous Exp.
-
9.59
% Of Sales
-
2.69%
EBITDA
-
50.44
EBITDA Margin
-
14.16%
Other Income
-
20.48
Interest
-
0.12
Depreciation
-
4.48
PBT
-
66.33
Tax
-
16.67
Tax Rate
-
25.13%
PAT
-
49.66
PAT before Minority Interest
-
49.66
Minority Interest
-
0.00
PAT Margin
-
13.94%
PAT Growth
-
 
EPS
-
23.42

Results Balance Sheet

Standalone Figures in Rs. Crores

Cash Flow

Standalone Figures in Rs. Crores

Financial Ratios

Standalone

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.